Press Release 05 Jan 2021 Autobahn Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference by autobahntx Read More
Press Release 05 Jan 2021 Autobahn Therapeutics Strengthens its Team to Support its Continued Growth by autobahntx Read More
Press Release 05 Jan 2021 Autobahn Therapeutics Completes Successful Pre-IND Meeting with FDA by autobahntx Read More
Press Release 05 Jan 2021 Autobahn Therapeutics Appoints Business Leader, Scott Forrest, Ph.D., as Chief Business Officer by autobahntx Read More
News 05 Jan 2021 Sehr gut: Autobahn roars out of stealth mode with $76M, new leitmotif in MS by autobahntx Read More
News 05 Jan 2021 ARCH-backed Autobahn launches with $76M to rebuild myelin and reverse MS by autobahntx Read More
Press Release 05 Jan 2021 Autobahn Therapeutics Launches with $76 Million Series B Financing to Develop Next Generation Therapies for CNS Disorders by autobahntx Read More